Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Verona Pharma PlcADS | 516,014 | 545,872 | +29,858 | $23.96M | $34.66M | 7.24% | +$10.69M |
| Merus N V | 680,845 | 811,021 | +130,176 | $28.63M | $34.14M | 7.13% | +$5.51M |
| Nuvalent Inc | 400,014 | 439,018 | +39,004 | $31.31M | $31.14M | 6.50% | -$177.9K |
| Akero Therapeutics Inc | 739,563 | 719,992 | -19,571 | $20.57M | $29.15M | 6.09% | +$8.57M |
| Insmed Incorporated(INSM) | 372,230 | 321,366 | -50,864 | $25.70M | $24.52M | 5.12% | -$1.18M |
| Kalvista Pharmaceuticals Inc | 612,173 | 1,698,984 | +1,086,811 | $5.19M | $19.61M | 4.10% | +$14.42M |
| Veracyte, Inc.(VCYT) | 503,281 | 633,832 | +130,551 | $19.93M | $18.79M | 3.93% | -$1.14M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 273,896 | 337,605 | +63,709 | $15.33M | $17.88M | 3.74% | +$2.55M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 1,230,400 | 1,309,224 | +78,824 | $16.27M | $16.08M | 3.36% | -$182.1K |
| UroGen Pharma Ltd.(URGN) | 1,120,473 | 1,381,158 | +260,685 | $11.93M | $15.28M | 3.19% | +$3.34M |
| Avidity Biosciences Inc | 543,651 | 411,312 | -132,339 | $15.81M | $12.14M | 2.54% | -$3.67M |
| Soleno Therapeutics Inc | 0 | 166,417 | +166,417 | $0 | $11.89M | 2.48% | +$11.89M |
| Ascendis Pharma A/SADR(ASND) | 51,491 | 75,751 | +24,260 | $7.09M | $11.81M | 2.47% | +$4.72M |
| Disc Medicine, Inc.(IRON) | 110,381 | 236,471 | +126,090 | $7.00M | $11.74M | 2.45% | +$4.74M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 1,178,300 | 2,060,240 | +881,940 | $9.51M | $11.50M | 2.40% | +$1.99M |
| 89bio Inc | 96,511 | 1,510,498 | +1,413,987 | $754.7K | $10.98M | 2.29% | +$10.23M |
| Erasca, Inc.(ERAS) | 7,543,901 | 7,367,996 | -175,905 | $18.94M | $10.09M | 2.11% | -$8.84M |
| Wave Life Sciences, Inc.SHS(WVE) | 608,897 | 1,050,374 | +441,477 | $7.53M | $8.49M | 1.77% | +$955.0K |
| Neurocrine Biosciences, Inc.(NBIX) | 0 | 72,583 | +72,583 | $0 | $8.03M | 1.68% | +$8.03M |
| Travere Therapeutics, Inc.(TVTX) | 277,365 | 408,849 | +131,484 | $4.83M | $7.33M | 1.53% | +$2.49M |
| Gossamer Bio, Inc.(GOSS) | 6,171,847 | 6,320,684 | +148,837 | $5.58M | $6.95M | 1.45% | +$1.37M |
| Gilead Sciences, Inc.(GILD) | 10,000 | 62,029 | +52,029 | $923.7K | $6.95M | 1.45% | +$6.03M |
| Helix Acquisition Corp IiCL A | 513,369 | 613,393 | +100,024 | $5.39M | $6.93M | 1.45% | +$1.54M |
| Elutia Inc.CL A(ELUT) | 1,782,271 | 2,670,056 | +887,785 | $6.67M | $6.76M | 1.41% | +$89.5K |
| Praxis Precision Medicines, Inc.(PRAX) | 72,516 | 166,074 | +93,558 | $5.58M | $6.29M | 1.31% | +$708.4K |
| Mineralys Therapeutics, Inc.(MLYS) | 0 | 338,354 | +338,354 | $0 | $5.37M | 1.12% | +$5.37M |
| Compugen Ltd.(CGEN) | 1,624,377 | 2,895,430 | +1,271,053 | $2.49M | $4.23M | 0.88% | +$1.74M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 65,955 | 81,331 | +15,376 | $3.65M | $4.18M | 0.87% | +$526.0K |
| Alkermes plcSHS(ALKS) | 0 | 124,871 | +124,871 | $0 | $4.12M | 0.86% | +$4.12M |
| Ocular Therapeutix, Inc.(OCUL) | 0 | 551,570 | +551,570 | $0 | $4.04M | 0.84% | +$4.04M |
| BridgeBio Pharma, Inc.(BBIO) | 0 | 111,000 | +111,000 | $0 | $3.84M | 0.80% | +$3.84M |
| Kura Oncology, Inc.(KURA) | 0 | 581,369 | +581,369 | $0 | $3.84M | 0.80% | +$3.84M |
| Celldex Therapeutics, Inc.(CLDX) | 264,560 | 205,962 | -58,598 | $6.69M | $3.74M | 0.78% | -$2.95M |
| Dianthus Therapeutics, Inc.(DNTH) | 0 | 190,334 | +190,334 | $0 | $3.45M | 0.72% | +$3.45M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 0 | 10,344 | +10,344 | $0 | $3.43M | 0.72% | +$3.43M |
| Cerus Corporation(CERS) | 1,587,228 | 2,456,537 | +869,309 | $2.44M | $3.41M | 0.71% | +$970.3K |
| TELA Bio, Inc.(TELA) | 3,065,649 | 2,771,288 | -294,361 | $9.26M | $3.38M | 0.71% | -$5.88M |
| Centessa Pharmaceuticals PlcADS | 598,952 | 232,758 | -366,194 | $10.03M | $3.35M | 0.70% | -$6.69M |
| Trevi Therapeutics, Inc.(TRVI) | 734,234 | 530,000 | -204,234 | $3.03M | $3.33M | 0.70% | +$308.7K |
| Blueprint Medicines Corp | 0 | 37,345 | +37,345 | $0 | $3.31M | 0.69% | +$3.31M |
| Structure Therapeutics IncADS | 152,395 | 188,069 | +35,674 | $4.13M | $3.26M | 0.68% | -$877.5K |
| Benitec Biopharma Inc.(BNTC) | 0 | 250,000 | +250,000 | $0 | $3.25M | 0.68% | +$3.25M |
| Liquidia Corporation(LQDA) | 0 | 214,057 | +214,057 | $0 | $3.16M | 0.66% | +$3.16M |
| PTC Therapeutics, Inc.(PTCT) | 0 | 60,389 | +60,389 | $0 | $3.08M | 0.64% | +$3.08M |
| Metsera Inc | 0 | 112,759 | +112,759 | $0 | $3.07M | 0.64% | +$3.07M |
| Biodesix, Inc.(BDSX) | 4,332,281 | 4,098,406 | -233,875 | $6.63M | $2.56M | 0.54% | -$4.07M |
| Delcath Systems, Inc.(DCTH) | 155,325 | 191,470 | +36,145 | $1.87M | $2.44M | 0.51% | +$567.3K |
| uniQure N.V.SHS(QURE) | 100,000 | 203,400 | +103,400 | $1.77M | $2.16M | 0.45% | +$390.0K |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 0 | 88,215 | +88,215 | $0 | $1.96M | 0.41% | +$1.96M |
| Solid Biosciences Inc | 0 | 452,239 | +452,239 | $0 | $1.67M | 0.35% | +$1.67M |
| Compass Therapeutics, Inc.(CMPX) | 0 | 874,869 | +874,869 | $0 | $1.66M | 0.35% | +$1.66M |
| C4 Therapeutics, Inc.(CCCC) | 1,221,131 | 882,300 | -338,831 | $4.40M | $1.41M | 0.29% | -$2.98M |
| KALA BIO, Inc.(KALA) | 231,070 | 246,079 | +15,009 | $1.60M | $1.41M | 0.29% | -$193.6K |
| Unicycive Therapeutics Inc | 2,486,709 | 2,413,489 | -73,220 | $1.97M | $1.39M | 0.29% | -$587.4K |
| ABIVAX Société AnonymeADS(ABVX) | 285,120 | 210,901 | -74,219 | $2.09M | $1.32M | 0.28% | -$768.9K |
| Kodiak Sciences Inc.(KOD) | 1,000,000 | 441,807 | -558,193 | $9.95M | $1.24M | 0.26% | -$8.71M |
| Sionna Therapeutics, Inc.(SION) | 0 | 114,138 | +114,138 | $0 | $1.19M | 0.25% | +$1.19M |
| InflaRx N.V.(IFRX) | 0 | 1,161,567 | +1,161,567 | $0 | $1.18M | 0.25% | +$1.18M |
| Mersana Therapeutics Inc | 0 | 3,088,505 | +3,088,505 | $0 | $1.06M | 0.22% | +$1.06M |
| Modular Med Inc | 1,272,015 | 958,881 | -313,134 | $1.74M | $1.05M | 0.22% | -$697.5K |
| Radiopharm Theranostics LimitedADS(RADX) | 187,406 | 187,406 | 0 | $841.5K | $901.4K | 0.19% | +$60.0K |
| Aardvark Therapeutics Inc | 0 | 119,496 | +119,496 | $0 | $897.4K | 0.19% | +$897.4K |
| Xenon Pharmaceuticals Inc.(XENE) | 0 | 10,121 | +10,121 | $0 | $339.6K | 0.07% | +$339.6K |
| Avadel Pharmaceuticals Plc | 0 | 39,366 | +39,366 | $0 | $308.2K | 0.06% | +$308.2K |
| Fractyl Health, Inc.(GUTS) | 176,922 | 237,448 | +60,526 | $364.5K | $282.6K | 0.06% | -$81.9K |
| Vaxart, Inc.(VXRT) | 1,077,782 | 683,825 | -393,957 | $713.6K | $278.3K | 0.06% | -$435.3K |
| Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT) | 104,828 | 104,828 | 0 | $3.6K | $4.9K | 0.00% | +$1.3K |
| BioAge Labs, Inc.(BIOA) | 39,974 | 0 | -39,974 | $231.4K | $0 | — | -$231.4K |
| Cogent Biosciences, Inc.(COGT) | 921,137 | 0 | -921,137 | $7.18M | $0 | — | -$7.18M |
| EyePoint, Inc.(EYPT) | 121,274 | 0 | -121,274 | $903.5K | $0 | — | -$903.5K |
| Geron Corporation(GERN) | 920,022 | 0 | -920,022 | $3.26M | $0 | — | -$3.26M |
| Incyte Corporation(INCY) | 49,000 | 0 | -49,000 | $3.38M | $0 | — | -$3.38M |
| Intra-Cellular Therapies Inc | 179,085 | 0 | -179,085 | $14.96M | $0 | — | -$14.96M |
| Karyopharm Therapeutics Inc.(KPTI) | 595,990 | 0 | -595,990 | $403.1K | $0 | — | -$403.1K |
| Olema Oncology, Inc.(OLMA) | 233,281 | 0 | -233,281 | $1.36M | $0 | — | -$1.36M |
| Pliant Therapeutics, Inc.(PLRX) | 1,315,601 | 0 | -1,315,601 | $17.33M | $0 | — | -$17.33M |
| Poseida Therapeutics Inc | 1,012,307 | 0 | -1,012,307 | $9.72M | $0 | — | -$9.72M |
| Scholar Rock Holding Corporation(SRRK) | 183,243 | 0 | -183,243 | $7.92M | $0 | — | -$7.92M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 124,388 | 0 | -124,388 | $5.23M | $0 | — | -$5.23M |
| Vaxcyte, Inc.(PCVX) | 40,788 | 0 | -40,788 | $3.34M | $0 | — | -$3.34M |
| Viridian Therapeutics, Inc.(VRDN) | 100,000 | 0 | -100,000 | $1.92M | $0 | — | -$1.92M |